Many people assume sleep apnea is stable, but the reality is very different, and some nights can be much worse than others, ...

ProSomnus announced today that it received FDA 510(k) clearance for its RPMO₂ obstructive sleep apnea (OSA) therapy device.

Variable aspects of obstructive sleep apnea were associated with an increased risk for major adverse cardio- and cerebrovascular events.

An estimated 1 billion people between the ages of 30 and 69 across the globe suffer from sleep apnea, particularly ...

Positive airway pressure therapy is linked with reduced pulmonary arterial pressures in patients with severe obstructive sleep apnea or obesity hypoventilation syndrome.

Nearly 30 million adults in the U.S. have obstructive sleep apnea (OSA)—and many don't even know it. If you've been waking up ...

Central sleep apnea (CSA) is fundamentally different from obstructive sleep apnea (OSA). The former is characterized by ...

The company, which is flush with cash from sales of its market-leading GLP-1 franchise, has been an active dealmaker.

SAN FRANCISCO, April 13, 2026 (GLOBE NEWSWIRE) -- ProSomnus Sleep Technologies (“the Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy® and pioneer in Smart Sleep Medicine™, today ...

A large international real-world study published in npj Digital Medicine suggests that the cardiovascular implications of ...

More than 150,000 people have registered interest in an upcoming sleep apnea risk detection solution from Sleep Cycle ahead of its commercial launch.

Santino Marella announced underwent successful surgery for sleep apnea.